We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.02 (11.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.19
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Apr 2022 15:44

RNS Number : 6981H
Nuformix PLC
07 April 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYW79Y38

Issuer Name

NUFORMIX PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting

3. Details of person subject to the notification obligation

Name

CPI Enterprises Limited

City of registered office (if applicable)

Redcar

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

04-Apr-2022

6. Date on which Issuer notified

07-Apr-2022

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.750000

0.000000

3.750000

26600000

Position of previous notification (if applicable)

4.320000

0.000000

4.320000

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYW79Y38

26600000

 

3.750000

 

Sub Total 8.A

26600000

3.750000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

07-Apr-2022

13. Place Of Completion

Wilton, Redcar, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLSSUFLWEESEDL
Date   Source Headline
14th Sep 20187:00 amRNSNXP001 Pre-Clinical Milestone Achieved
28th Aug 201812:55 pmRNSConvertible Loan Amendment
16th Aug 20187:00 amRNSAnnual Report and Notice of AGM
26th Jul 20182:00 pmRNSFinal Results
9th Jul 20189:33 amRNSHolding(s) in Company
2nd Jul 20187:00 amRNSOperational Update
26th Jun 20188:00 amRNSCollaboration with SGSC
11th May 20187:00 amRNSDr Chris Blackwell Appointed NED
24th Apr 201811:54 amRNSHolding(s) in Company
11th Apr 20184:41 pmRNSStmnt re Share Price Movement
2nd Mar 20181:30 pmRNSUpdate re: Broker
27th Feb 20189:37 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSNXP002 Pilot Study in Lung and Liver Fibrosis
15th Dec 20177:30 amRNSAgreement to License NXP001
14th Dec 20177:00 amRNSDr Andy Richards Chairs Advisory Panel - New Appts
12th Dec 20174:40 pmRNSSecond Price Monitoring Extn
12th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20177:00 amRNSGrant of Warrants
1st Dec 20177:30 amRNSAppointment of Broker
10th Nov 201710:19 amRNSHolding(s) in Company
1st Nov 201712:23 pmRNSHolding(s) in Company
23rd Oct 20177:30 amRNSHolding(s) in Company
19th Oct 20177:00 amRNSNXP001 agreement for pilot bioequivalence study
16th Oct 20177:00 amRNSAdmission and First Dealings
16th Oct 20177:00 amRNSCancellation Notice and Re-Admission
13th Oct 20173:44 pmRNSChange of Name
13th Oct 201712:35 pmRNSResult of Meeting and Completion of Acquisition
13th Oct 20177:00 amRNSHalf-year Report
22nd Sep 20177:00 amRNSFinal Results and Annual Report
15th Sep 20172:15 pmRNSProspectus re: Proposed Acquisition of Nuformix
20th Apr 20177:00 amRNSConvertible Loan Agreement
23rd Dec 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSAccounts for the period ended 31 March 2016
21st Sep 20167:00 amRNSNew Accounting Ref Date
16th Sep 20161:03 pmRNSPossible Acquisition and Suspension of Trading
29th Mar 20167:00 amRNSHalf Yearly Report
24th Feb 20167:00 amRNSBroker Appointment and Corporate Update
17th Dec 20157:00 amRNSPublication of Prospectus and First Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.